Kittikasemsook, S. ., Torvorapanit, P. ., & Nakaranurack, C. . (2026). Treatment outcomes and factors associated with treatment failure among patients with mild-to-moderate COVID-19 receiving five-days of oral molnupiravir vs. three-days of intravenous remdesivir in a real-world practice. Chulalongkorn Medical Journal, 70(1). Retrieved from https://he05.tci-thaijo.org/index.php/CMJ/article/view/7322